| Multifaceted immunomodulatory effects of the BTK inhibitors ibrutinib and acalabrutinib on different immune cell subsets–beyond B lymphocytes S Zhu, S Gokhale, J Jung, E Spirollari, J Tsai, J Arceo, BW Wu, E Victor, ... Frontiers in cell and developmental biology 9, 727531, 2021 | 27 | 2021 |
| Clinical trials of the BTK inhibitors ibrutinib and acalabrutinib in human diseases beyond B cell malignancies S Zhu, J Jung, E Victor, J Arceo, S Gokhale, P Xie Frontiers in oncology 11, 737943, 2021 | 18 | 2021 |
| Mitochondrial fission factor is a novel interacting protein of the critical B cell survival regulator TRAF3 in B lymphocytes Y Liu, S Gokhale, J Jung, S Zhu, C Luo, D Saha, JY Guo, H Zhang, S Kyin, ... Frontiers in immunology 12, 670338, 2021 | 15 | 2021 |
| TRAF3: a novel regulator of mitochondrial physiology and metabolic pathways in B lymphocytes J Jung, S Gokhale, P Xie Frontiers in Oncology 13, 1081253, 2023 | 4 | 2023 |
| Upregulated expression of the IL-9 receptor on TRAF3-deficient B lymphocytes confers ig isotype switching responsiveness to IL-9 in the presence of antigen receptor engagement … S Gokhale, E Victor, J Tsai, E Spirollari, B Matracz, S Takatsuka, J Jung, ... The Journal of Immunology 210 (8), 1059-1073, 2023 | 2 | 2023 |
| Abstract PO-019: Ubiquitin E3 ligase OSTM1 regulates the cAMP/PKA/CREB pathway and suppresses B-cell malignancies MU Tariq, J Shen, J Jung, N Sheshadri, J Yan, R Li, K Lu, T Liu, H Li, ... Blood Cancer Discovery 5 (3_Supplement), PO-019-PO-019, 2024 | | 2024 |
| Abstract PO-035: Genome-wide CRISPR knockout screen identifies sialylation as a tumor suppressive mechanism in B-cell malignancies N Sheshadri, R Li, MU Tariq, J Shen, J Jung, J Yan, K Lu, Z Shen, P Xie, ... Blood Cancer Discovery 5 (3_Supplement), PO-035-PO-035, 2024 | | 2024 |
| Abstract PO-020: ZBTB24 is a novel tumor suppressor and cooperates with CDKN2A to suppress B-cell lymphomagenesis R Li, N Sheshadri, J Shen, J Yan, J Jung, MU Tariq, YL Wang, P Xie, ... Blood Cancer Discovery 5 (3_Supplement), PO-020-PO-020, 2024 | | 2024 |
| Abstract PO-018: Commensal bacteria are required for chronic inflammation and B lymphoma development in myeloid cell-specific TRAF3-deficient mice J Jung, S Zhu, AI Lalani, J Shakarchi, GG Wu, WX Zong, L Zhao, P Xie Blood Cancer Discovery 5 (3_Supplement), PO-018-PO-018, 2024 | | 2024 |
| Effects of IL-9 on TRAF3-deficient B cell activation J Jung, S Gokhale, E Victor, J Tsai, E Spirollari, B Matracz, S Takatsuka, ... The Journal of Immunology 210 (1_Supplement), 60.05-60.05, 2023 | | 2023 |
| Regulation of myeloid-derived suppressor cell expansion by TRAF3 during chronic inflammation J Jung, S Zhu, A Lalani, DB Sant’Angelo, LR Covey, ... The Journal of Immunology 208 (1_Supplement), 164.14-164.14, 2022 | | 2022 |
Ping XieRutgers University在 dls.rutgers.edu 的电子邮件经过验证
Ping XieRutgers University在 dls.rutgers.edu 的电子邮件经过验证
Almin LalaniAmgen在 amgen.com 的电子邮件经过验证